Vnitr Lek 2023, 69(7):E4-E9 | DOI: 10.36290/vnl.2023.092

Association of Alzheimer disease and optical coherence tomography parameters - systematic review

Adam Ernest1, Ludmila Brunerová2
1 Oční klinika 3. LF UK a Fakultní nemocnice Královské Vinohrady, Praha
2 Interní klinika 3. LF UK a Fakultní nemocnice Královské Vinohrady, Praha

: Alzheimer disease (AD) as the most common cause of dementia, is affecting approximately 3-40 % of the elderly population and its incidence grows. It is a great burden for healthcare system. Standard diagnostic neurocognitive examination is time consuming and quite expensive. Therefore there is need for fast and accurate screening test. The retina of the eye is embryologically extension of the brain so it is assumed that there is correlation between status of the retina detected by optical coherence tomography and cognitive function. The aim of this study is to create a systematic review of studies which analysed correlation betwen retinal nerve fiber layer thickness (RNFL) and cognitive functions in patients with Alzheimer disease.

Methods: Relevant studies from PubMed and Google scholar were searched using key words: Optical coherence tomography, dementia, retinal nerve fibre layer, cognitive function. Only results of studies where RNFL was measured with OCT scan and their association with Alzheimer disease were then analysed.

Results: There were 16 studies eligible for the analysis. Most studies consistently proved association between RNFL thickness at the OCT and the presence of Alzheimer disease. In nearly every available study there is thinning of RNFL in superior and inferior quadrants, while in nasal and temporal quadrants there was no significant thinning present.

Conclusion: So far as the results are being reviewed, there is an evidence that patients with Alzheimer disease have their retinal nerve fibre layer thickness decreased. This finding could lead to faster diagnosis of this disease and better therapeutical approach in this group of patients. There is sought for other studies with larger cohort and with modern imaging devices and software.

Keywords: Optical coherence tomography, dementia, cognitive function, retinal nerve fiber layer thickness.

Accepted: October 26, 2023; Published: October 26, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ernest A, Brunerová L. Association of Alzheimer disease and optical coherence tomography parameters - systematic review. Vnitr Lek. 2023;69(7):E4-9. doi: 10.36290/vnl.2023.092.
Download citation

References

  1. Khan S, Barve KH, Kumar MS. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease. Curr Neuropharmacol. 2020;18(11):1106-1125. doi: 10.2174/1570159X18666200528142429. PMID: 32484110; PMCID: PMC7709159. Go to original source... Go to PubMed...
  2. Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789 Go to original source... Go to PubMed...
  3. Burns A, Iliffe S. Alzheimer's disease. BMJ. 2009 Feb 5;338:b158. doi: 10.1136/bmj.b158. Erratum in: BMJ. 2009 Apr 1. doi: 10.1136/bmj.b1349. Go to original source... Go to PubMed...
  4. Patton N, Aslam T, Macgillivray T, et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005 Apr;206(4):319-48. doi: 10.1111/j.1469-7580.2005.00395.x. Go to original source... Go to PubMed...
  5. Galetta KM, Calabresi PA, Frohman EM, et al. Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics. 2011 Jan;8(1):117-32. doi: 10.1007/s13311-010-0005-1 Go to original source... Go to PubMed...
  6. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71 Go to original source... Go to PubMed...
  7. Paquet C, Boissonnot M, Roger F et al. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett. 2007 Jun 13;420(2):97-9. doi: 10.1016/j.neulet.2007. 02. 09 Go to original source...
  8. Kesler A, Vakhapova V, Korczyn AD, et al. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg. 2011 Sep;113(7):523-6. doi: 10.1016/j.clineuro.2011. 02. 014 Go to original source...
  9. Oktem EO, Derle E, Kibaroglu S, et al. The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci. 2015 Jul;36(7):1141-6. doi: 10.1007/s10072-014-2055-3 Go to original source... Go to PubMed...
  10. Ascaso FJ, Cruz N, Modrego PJ, et al. Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. J Neurol. 2014 Aug;261(8):1522-30. doi: 10.1007/s00415-014-7374-z. Epub 2014 May 21 Go to original source... Go to PubMed...
  11. Liu D, Zhang L, Li Z, et al. Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer's disease. BMC Neurol. 2015 Feb 21;15:14. doi: 10.1186/s12883-015-0268-6 Go to original source... Go to PubMed...
  12. Moreno­‑Ramos T, Benito­‑León J, Villarejo A, et al. Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. J Alzheimers, DiS. 2013;34(3):659-64. doi: 10.3233/JAD-121975 Go to original source... Go to PubMed...
  13. Salobrar­‑Garcia E, Hoyas I, Leal M, et al. Analysis of Retinal Peripapillary Segmentation in Early Alzheimer's Disease Patients. Biomed Res Int. 2015;2015:636548. doi: 10.1155/2015/636548. Epub 2015 Oct 18 Go to original source... Go to PubMed...
  14. Iseri PK, Altinaş O, Tokay T, et al. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol. 2006 Mar;26(1):18-24. doi: 10.1097/01.wno.0000204645.56873.26 Go to original source... Go to PubMed...
  15. Marziani E, Pomati S, Ramolfo P, et al. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral­‑domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013 Sep 5;54(9):5953-8. doi: 10.1167/iovs.13-12046 Go to original source... Go to PubMed...
  16. Garcia­‑Martin E, Bambo MP, Marques ML, et al. Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer's disease. Acta Ophthalmol. 2016 Sep;94(6):e454-9. doi: 10.1111/aos.12977 Go to original source... Go to PubMed...
  17. Cunha JP, Proença R, Dias­‑Santos A et al. OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina. Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1827-1835. doi: 10.1007/s00417-017-3715-9 Go to original source... Go to PubMed...
  18. Mei X, Qiu C, Zhou Q, et al. Changes in retinal multilayer thickness and vascular network of patients with Alzheimer's disease. Biomed Eng Online. 2021 Oct 3;20(1):97. doi: 10.1186/s12938-021-00931-2 Go to original source... Go to PubMed...
  19. Berisha F, Feke GT, Trempe CL et al. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 2007 May;48(5):2285-9. doi: 10.1167/iovs.06-1029 Go to original source... Go to PubMed...
  20. Kirbas S, Turkyilmaz K, Anlar O et al. Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol. 2013 Mar;33(1):58-61. doi: 10.1097/WNO.0b013e318267fd5f Go to original source... Go to PubMed...
  21. Polo V, Rodrigo MJ, Garcia­‑Martin E, et al. Visual dysfunction and its correlation with retinal changes in patients with Alzheimer's disease. Eye (Lond). 2017 Jul;31(7):1034-1041. doi: 10.1038/eye.2017.23 Go to original source... Go to PubMed...
  22. Jindahra P, Hengsiri N, Witoonpanich P, et al. Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Layer Thickness in Alzheimer's Disease Using Optical Coherence Tomography. Clin Ophthalmol. 2020 Oct 2;14:2995-3000. doi: 10.2147/OPTH.S276625 Go to original source... Go to PubMed...
  23. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011 Sep;10(9):819-28. doi: 10.1016/S1474-4422(11)70072-2 Go to original source... Go to PubMed...
  24. Alber J, Goldfarb D, Thompson LI, et al. Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. Alzheimers Dement. 2020 Jan;16(1):229-243. doi: 10.1002/alz.12006. Go to original source... Go to PubMed...
  25. Jones AL, Sheen NJ, North RV, et al. The Humphrey optical coherence tomography scanner: quantitative analysis and reproducibility study of the normal human retinal nerve fibre layer. Br J Ophthalmol. 2001 Jun;85(6):673-7. doi: 10.1136/bjo.85. 6. 673 Go to original source...
  26. Choe S, Jang M, Kim YK, et al. Clinical usefulness of layer­‑by­‑layer deviation maps of Spectralis OCT: comparison with Cirrus OCT. Br J Ophthalmol. 2022 Aug 24:bjophthalmol-2022-321054. doi: 10.1136/bjo-2022-321054 Go to original source... Go to PubMed...
  27. Fickweiler W, Wolfson EA, Paniagua SM, et al Association of Cognitive Function and Retinal Neural and Vascular Structure in Type 1 Diabetes. J Clin Endocrinol Metab. 2021 Mar 25;106(4):1139-1149. doi: 10.1210/clinem/dgaa921 Go to original source... Go to PubMed...
  28. Brunerová L, Raudenská J, Sotorník R, et al. Letter to the Editor from Brunerová et al: "Association of Cognitive Function and Retinal Neural and Vascular Structure in Type 1 Diabetes". J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3281-e3282. doi: 10.1210/clinem/dgab350. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.